Rhythm

iBeat, the Lifesaving Smartwatch, Extends Seed Round to $4.5 Million; Builds Out Executive Bench with Hires from Apple and Stanford

SAN FRANCISCO–(BUSINESS WIRE)–iBeat, a wearable technology company empowering people to live longer lives, today announced it has closed another $3 million in funding, bringing its total seed stage funding to $4.5 million. New investors include WTI, SV Tech Ventures, Lee Equity, and renowned entrepreneurs and angel investors Michael Rubin, Mark Burg, and Harald Ludwig. They join […]

Clinical Trial to Evaluate Medtronic Cryoablation as First-Line Treatment for Patients With Symptomatic Paroxysmal Atrial Fibrillation

Press Release DUBLIN – July 11, 2017 – Medtronic plc (NYSE: MDT) today announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the safety and effectiveness of performing pulmonary vein isolation (PVI) with the Arctic Front Advance(TM) Cryoballoon in patients with symptomatic paroxysmal atrial fibrillation (AF) prior […]

Cardiac Insight’s “Cardea SOLO” Supports Top Arrhythmia Experts’ Acknowledgement: Wearable Cardiac Monitors Are Effective For Tracking Atrial Fibrillation Following Cardiac Ablation

KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a U.S. developer of wearable medical devices and diagnostic software, announced today that its FDA-approved Cardea SOLO™ ECG monitoring system is available for diagnosing atrial fibrillation following cardiac ablation. The company’s cardiac monitoring device supports a recent formal consensus statement by experts from 11 leading […]

iRhythm Release: Research Collaboration Demonstrates Use Of Deep Learning To Develop Expert Level Comprehensive Cardiac Arrhythmia Detection Algorithm

SAN FRANCISCO, July 10, 2017 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care announced a collaboration with the Stanford Machine Learning Group that has resulted in the development of a deep learning algorithm capable of expert level […]

BioSig Technologies Enters Into Strategic Development Work With Health Research International

Minneapolis, MN, July 11, 2017 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need within the $4+ billion electrophysiology (EP) marketplace, today announced that the Company has engaged Health Research International (HRI) to compile essential market […]

BIOTRONIK’s New Quadripolar CRT-P with More Pacing Options Now Available in Japan

Evity 8 HF-T QP Offers a Host of Functions Including LV VectorOpt, RF Telemetry, MRI AutoDetect and BIOTRONIK Home Monitoring TOKYO, Japan and BERLIN, Germany, July 10, 2017 – BIOTRONIK has announced the launch of its Evity cardiac resynchronization therapy pacemaker (CRT-P) in the Japanese market. It is the company’s highest performing […]

CathVision Raises Venture Funding to Market New EP Recording System

COPENHAGEN, Denmark, July 7, 2017 /PRNewswire/ — Medical device company CathVision has signed a multi-million venture investment from Scandinavian-based investors VF Venture and Borean Innovation. The investment is directed at developing and market the company’s superior electrophysiology (EP) recording system for treating cardiac arrhythmia.   Approximately 2% of the Western population suffers from cardiac […]

“Cardiologs ECG Analysis Platform” Receives FDA Clearance

PARIS–(BUSINESS WIRE)–Cardiologs Technologies SAS announced today that it has received FDA clearance of its Cardiologs ECG Analysis Platform, a cloud-based cardiac monitoring-analysis web service powered by artificial intelligence (AI). Cardiologs aids physicians in screening for atrial fibrillation (AFib) and other arrhythmias using long-term ambulatory ECG monitoring recordings. The Cardiologs system is also CE-marked […]

CardioFocus Announces Initiation Of Three Major Studies Featuring The HeartLight System For The Treatment Of Atrial Fibrillation

MARLBOROUGH, Mass., June 29, 2017/PRNewswire/ — CardioFocus, Inc., a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF), today announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical studies currently underway. Collectively, up to 1,000 AF patients will be […]